Clinical Trial Update: Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the Guidant Microwave Ablation System for atrial fibrillation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Guidant Microwave Ablation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | Phase 3 | Status: TERMINATED